Point of Care Testing for Infectious Disease Market, by Infectious Disease Testing Technology (Nucleic Acid Testing, Polymerase Chain Reaction, Isothermal DNA Amplification, Enzyme Linked Immunosorbent Assay, Hemagglutination Assay, LateralFlow Assay, Microscopy Test) and, by Infectious Disease Testing end Users (Hospitals, Clinics, Ambulatory, Others): Opportunity Analysis and Industry Forecast, 2023-2032

The report includes potential revenue forecast of the market for the next ten years along with market trends, opportunities, and competition intelligence. In addition, the report offers various intellectual tables and charts/graphs to understand the complexities of the market. The report will help clients in gaining much recent and first-hand insights of overall global market and regional level penetration of each segment. Furthermore, the study comprises information of key players in the market and its financial results, company trends, segmental revenue, product/service offerings, SWOT analysis, and brand positioning.

Besides revenue forecasting, the report will track the recent growth trends, company market share, new product/service launch, and impact of M&A activities across the market. The competition section of the study will highlight the revenue share and potential of leading competitors of the market. The report covers profiling of top 10 competitors of the market. Further, the study includes revenue forecast for 4 regions and 20+ key countries. Readers can find forecasts for the Point of care testing for infectious disease market in North America, Europe, Asia-Pacific, and LAMEA.

Key Companies identified in the report are Roche Diagnostics, Abbott Laboratories, Cepheid, Bio-Rad laboratories, Hologic, Ortho Clinical Diagnostics, bioMerieux, Danaher Corporation, Thermo Fisher Scientific, Siemens Healthcare

  Point of Care Testing for Infectious Disease Market, by Infectious Disease Testing Technology Report Highlights

Aspects	Details
By Infectious Disease Testing Technology	Nucleic Acid Testing Polymerase Chain Reaction Isothermal DNA Amplification Enzyme Linked Immunosorbent Assay Hemagglutination Assay LateralFlow Assay Microscopy Test
By Infectious Disease Testing end Users	Hospitals Clinics Ambulatory Others
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Cepheid, bioMerieux, Roche Diagnostics, Bio-Rad laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthcare, Ortho Clinical Diagnostics, Hologic, Abbott Laboratories

^*Terms and Conditions Apply